BIT
ORKA

BlackRock Institutional Trust’s Oruka Therapeutics ORKA Stock Holding History

BlackRock Institutional Trust’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-48
Closed -$115K – 4046
2013
Q3 		$115K Buy
48
+11
+30% +$22.9K ﹤0.01% 3747
2013
Q2 		$72K Buy
+37
New +$113K ﹤0.01% 3779

Other funds holding ORKA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock Institutional Trust's ORKA Position: Q4 2013 in Review

BlackRock Institutional Trust sold out of Oruka Therapeutics (ORKA) in Q4 2013, closing a stake of 48 shares — an estimated $115K sold.

BlackRock Institutional Trust first reported a position in ORKA in Q2 2013 and held it in 2 quarters. The position peaked at $115K in Q3 2013. 14 funds tracked by Wall St. Rank hold ORKA as of Q4 2013.

  • BlackRock Institutional Trust reported no remaining Oruka Therapeutics position as of Q4 2013 after selling out during the quarter.
  • BlackRock Institutional Trust sold 48 Oruka Therapeutics shares in Q4 2013, an estimated $115K.
  • BlackRock Institutional Trust first reported a position in Oruka Therapeutics in Q2 2013 and held it in 2 quarters.
  • BlackRock Institutional Trust's Oruka Therapeutics position peaked at $115K in Q3 2013.
  • 14 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q4 2013.

Based on BlackRock Institutional Trust's 13F filing for Q4 2013, filed 12 Feb 2014.